Provided by Tiger Fintech (Singapore) Pte. Ltd.

Neurocrine Biosciences

126.55
-0.7600-0.60%
Post-market: 126.550.00000.00%17:01 EDT
Volume:1.58M
Turnover:199.40M
Market Cap:12.52B
PE:42.79
High:128.38
Open:127.88
Low:125.53
Close:127.31
Loading ...

Post-Bell | U.S. Stocks Close Lower; Pony AI Soars 48%; WeRide Surges 32%; Hims & Hers Jumps 18%; Tesla Drops 2%

Tiger Newspress
·
07 May

Neurocrine Biosciences' Ingrezza Q1 Sales Prove Resilient, Analysts Boost Price Target

Benzinga
·
07 May

Neurocrine Price Target Cut to $154.00/Share From $160.00 by Piper Sandler

Dow Jones
·
07 May

Neurocrine Biosciences Stock Rises on Revenue Beat as Ingrezza Sales Climb

Dow Jones
·
06 May

Neurocrine Biosciences Up Over 13%, on Pace for Largest Percent Increase Since November 2017 -- Data Talk

Dow Jones
·
06 May

Stock Track | Neurocrine Biosciences Soars 16.71% on Strong Q1 Earnings, INGREZZA Sales Growth, and Analyst Upgrades

Stock Track
·
06 May

Neurocrine price target raised to $130 from $115 at Wedbush

TIPRANKS
·
06 May

Wedbush Sticks to Its Buy Rating for Neurocrine (NBIX)

TIPRANKS
·
06 May

RBC Raises Price Target on Neurocrine Biosciences to $145 From $137, Keeps Outperform Rating

MT Newswires Live
·
06 May

Neurocrine price target raised to $165 from $155 at Guggenheim

TIPRANKS
·
06 May

Neurocrine Is Maintained at Buy by Needham

Dow Jones
·
06 May

Neurocrine Biosciences Inc : Needham Raises Target Price to $139 From $138

THOMSON REUTERS
·
06 May

Stock Track | Neurocrine Biosciences Soars 10.28% Pre-market on Strong Q1 Earnings and Analyst Upgrades

Stock Track
·
06 May

Neurocrine Biosciences Inc : Bofa Global Research Raises Price Objective to $183 From $179

THOMSON REUTERS
·
06 May

Stock Track | Neurocrine Biosciences Surges 7.87% on Strong Q1 Earnings Beat and INGREZZA Sales Growth

Stock Track
·
06 May

Neurocrine Biosciences (NBIX) Q1 Earnings Miss Estimates

Zacks
·
06 May

Neurocrine Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
06 May

Neurocrine Biosciences Q1 Non-GAAP Earnings Fall, Sales Rise; Maintains 2025 Guidance

MT Newswires Live
·
06 May

Neurocrine: Q1 Earnings Snapshot

Associated Press Finance
·
06 May

Neurocrine Biosciences Q1 Adj. EPS $0.70 Beats $0.54 Estimate, Sales $572.60M Beat $559.33M Estimate

Benzinga
·
06 May